700
Participants
Start Date
December 22, 2020
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
Troriluzole
Troriluzole - 2 100mg capsules QD for the first two weeks.
Placebo
Matching placebo - 2 140mg capsules QD from week two through week ten.
Manhattan Behavioral Medicine, PLLC, New York
Richmond Behavioral Associates, Staten Island
Bioscience Research, LLC, Mount Kisco
Bio Behavioral Institute, Great Neck
Integrative Clinical Trials, LLC, Brooklyn
Neurobehavioral Research, Inc, Cedarhurst
Suburban Research Associates, Media
CBH Health, Gaithersburg
Pharmasite Research, Inc., Pikesville
iResearch Atlanta, LLC, Decatur
iResearch Savannah, Savannah
Medical Research Group of Central Florida, Orange City
Conquest Research LLC, Winter Park
APG Research, LLC, Orlando
Combined Research Orlando Phase I-IV, Orlando
Omega Research Consultants, Orlando
Research in Miami Inc, Hialeah
Health Care Family Rehab & Research, Miami
MedBio Trials, Pembroke Pines
Central Miami Medical Institute, Miami
Advanced Clinical Research Network, Coral Gables
Behavioral Clinical Research, North Miami
South Florida Research Phase I-IV , Inc., Miami Springs
FIRC, Miami
Florida Research Center, Inc., Miami
Innovative Clinical Research, Inc., Lauderhill
Neurobehaviorial Institute, Weston
Boca Raton Medical Institute, Boca Raton
Stedman Clinical Trials, Tampa
Accel Research Sites, Lakeland
Precise Research Centers, Flowood
Clinical Inquest Center, Ltd, Beavercreek
Michigan Clinical Research Institute PC, Ann Arbor
Revive Research Institute, Elgin
AMR-Baber Research, Inc, Naperville
Uptown Research Institute, Chicago
Psychiatric Care and Research Center, O'Fallon
Collective Medical Research, Overland Park
Central States Research, LLC, Tulsa
Relaro Medical Trials, Dallas
North Texas Clinical Trials, Fort Worth
Baylor College of Medicine, Houston
Texas Center for Drug Development, Inc., Houston
Mt.Olympus Medical Research LLC, Missouri City
BioBehavioral Research of Austin, Austin
Northwest Clinical Trials, Boise
IMA Clinical Research, Phoenix
NoeisisPharma, LLC, Phoenix
Metropolitan Neuro Behavioral Institute, Chandler
Altea Research, Las Vegas
Clarity Clinical Research, Los Angeles
Collaborative Neuroscience Research, Torrance
CITrials (Clinical Innovations), Bellflower
Pharmacology Research Institute, Los Alamitos
Behavioral Research Specialists, LLC, Glendale
WR-PRI, LLC (Encino), Encino
California Neuroscience Research Medical Group, Inc, Sherman Oaks
Excell Research, Inc, Oceanside
Axiom Research, LLC, Colton
Anderson Clinical Research, Redlands
NRC Research Institute, Orange
Stanford University, Stanford
Lumos Clinical Research Center, LLC, San Jose
Northwest Clinical Research Center, Bellevue
Yale University / Connecticut Mental Health Center, New Haven
Comprehensive Psychiatric Care, Norwich
Massachusetts General Hospital, Boston
Boston Clinical Trials, Boston
ActivMed Practices and Research, Methuen
Sisu at RMG, Springfield
Hassman Research Institute, Berlin
Bio Behavioral Health, Toms River
Comprehensive Psychiatric Care Providers, Providence
Lead Sponsor
Biohaven Pharmaceuticals, Inc.
INDUSTRY